|
Volumn 138, Issue 6, 2001, Pages 403-
|
Treatment of hyponatremic encephalopathy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
5 FLUORO 2 METHYL N (4 (5H PYRROLO(2,1 C) (1,4)BENZODIAZEPIN 10 (11H) YLCARBONYL) 3 CHLOROPHENYL)BENZAMIDE;
5-FLUORO-2-METHYL-N-(4-(5H-PYRROLO(2,1-C)-(1,4)BENZODIAZEPIN-10-(11H)-YLCARBONYL)-3-CHLOROPHENYL)BENZAMIDE;
AZEPINE DERIVATIVE;
BENZAMIDE DERIVATIVE;
SODIUM CHLORIDE;
VASOPRESSIN RECEPTOR;
HUMAN;
HYPONATREMIA;
LIVER CIRRHOSIS;
METABOLIC ENCEPHALOPATHY;
METABOLISM;
NOTE;
SCHWARTZ BARTTER SYNDROME;
AZEPINES;
BENZAMIDES;
BRAIN DISEASES, METABOLIC;
HUMAN;
HYPONATREMIA;
INAPPROPRIATE ADH SYNDROME;
LIVER CIRRHOSIS;
RECEPTORS, VASOPRESSIN;
SODIUM CHLORIDE;
|
EID: 0035662117
PISSN: 00222143
EISSN: None
Source Type: Journal
DOI: 10.1067/mlc.2001.119857 Document Type: Letter |
Times cited : (2)
|
References (10)
|